Literature DB >> 27358279

The contribution of glycosaminoglycans to the mechanical behaviour of the posterior human sclera.

Barbara J Murienne1, Michelle L Chen2, Harry A Quigley3, Thao D Nguyen2.   

Abstract

We characterized the structural and mechanical changes after experimental digestion of sulfated glycosaminoglycans (s-GAGs) in the human posterior sclera, using ultrasound thickness measurements and an inflation test with three-dimensional digital image correlation (3D-DIC). Each scleral specimen was first incubated in a buffer solution to return to full hydration, inflation tested, treated in a buffer solution with chondroitinase ABC (ChABC), then inflation tested again. After each test series, the thickness of eight locations was measured. After enzymatic treatment, the average scleral thickness decreased by 13.3% (p < 0.001) and there was a stiffer overall stress-strain response (p < 0.05). The stress-strain response showed a statistically significant increase in the low-pressure stiffness, high-pressure stiffness and hysteresis. Thus, s-GAGs play a measurable role in the mechanical behaviour of the posterior human sclera.
© 2016 The Author(s).

Entities:  

Keywords:  chondroitinase ABC; glaucoma; glycosaminoglycans; mechanical testing; myopia; sclera

Mesh:

Substances:

Year:  2016        PMID: 27358279      PMCID: PMC4938097          DOI: 10.1098/rsif.2016.0367

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  70 in total

1.  Prevalence of lattice degeneration and its relation to axial length in severe myopia.

Authors:  J M Celorio; R C Pruett
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

Review 2.  The sclera and myopia.

Authors:  Jody A Summers Rada; Setareh Shelton; Thomas T Norton
Journal:  Exp Eye Res       Date:  2005-10-03       Impact factor: 3.467

3.  A study of the interactions between monomeric tropocollagen and glycosaminoglycans.

Authors:  B Obrink
Journal:  Eur J Biochem       Date:  1973-03-01

4.  Proteoglycan composition in the human sclera during growth and aging.

Authors:  J A Rada; V R Achen; S Penugonda; R W Schmidt; B A Mount
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

5.  The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix.

Authors:  E C Johnson; J C Morrison; S Farrell; L Deppmeier; C G Moore; M R McGinty
Journal:  Exp Eye Res       Date:  1996-06       Impact factor: 3.467

6.  Quantitative mapping of collagen fiber orientation in non-glaucoma and glaucoma posterior human sclerae.

Authors:  Jacek K Pijanka; Baptiste Coudrillier; Kimberly Ziegler; Thomas Sorensen; Keith M Meek; Thao D Nguyen; Harry A Quigley; Craig Boote
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-07       Impact factor: 4.799

7.  Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.

Authors:  H A Quigley; E M Addicks; W R Green; A E Maumenee
Journal:  Arch Ophthalmol       Date:  1981-04

8.  Reduced extracellular matrix in mammalian sclera with induced myopia.

Authors:  T T Norton; J A Rada
Journal:  Vision Res       Date:  1995-05       Impact factor: 1.886

9.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.

Authors:  A Sommer; J M Tielsch; J Katz; H A Quigley; J D Gottsch; J Javitt; K Singh
Journal:  Arch Ophthalmol       Date:  1991-08

10.  Effect of dermatan sulfate glycosaminoglycans on the quasi-static material properties of the human medial collateral ligament.

Authors:  Trevor J Lujan; Clayton J Underwood; Heath B Henninger; Brent M Thompson; Jeffrey A Weiss
Journal:  J Orthop Res       Date:  2007-07       Impact factor: 3.494

View more
  16 in total

1.  Collagen fiber interweaving is central to sclera stiffness.

Authors:  Bingrui Wang; Yi Hua; Bryn L Brazile; Bin Yang; Ian A Sigal
Journal:  Acta Biomater       Date:  2020-06-23       Impact factor: 8.947

2.  Dasatinib inhibits peripapillary scleral myofibroblast differentiation.

Authors:  Amanda Chow; Liam McCrea; Elizabeth Kimball; Julie Schaub; Harry Quigley; Ian Pitha
Journal:  Exp Eye Res       Date:  2020-03-13       Impact factor: 3.467

3.  Factors affecting optic nerve head biomechanics in a rat model of glaucoma.

Authors:  Stephen A Schwaner; Andrew J Feola; C Ross Ethier
Journal:  J R Soc Interface       Date:  2020-04-01       Impact factor: 4.118

4.  The inflation response of the human lamina cribrosa and sclera: Analysis of deformation and interaction.

Authors:  Dan E Midgett; Joan L Jefferys; Harry A Quigley; Thao D Nguyen
Journal:  Acta Biomater       Date:  2020-02-08       Impact factor: 8.947

5.  Experimental myopia increases and scleral crosslinking using genipin inhibits cyclic softening in the tree shrew sclera.

Authors:  Alexander M Levy; Massimo A Fazio; Rafael Grytz
Journal:  Ophthalmic Physiol Opt       Date:  2018-05       Impact factor: 3.117

Review 6.  Glaucoma and biomechanics.

Authors:  Babak N Safa; Cydney A Wong; Jungmin Ha; C Ross Ethier
Journal:  Curr Opin Ophthalmol       Date:  2022-03-01       Impact factor: 3.761

7.  Effect of different preconditioning protocols on the viscoelastic inflation response of the posterior sclera.

Authors:  Gianfranco Bianco; Alexander M Levy; Rafael Grytz; Massimo A Fazio
Journal:  Acta Biomater       Date:  2021-04-29       Impact factor: 10.633

Review 8.  Glaucoma in mucopolysaccharidoses.

Authors:  Weijing Kong; Jing Zhang; Cheng Lu; Yingxue Ding; Yan Meng
Journal:  Orphanet J Rare Dis       Date:  2021-07-15       Impact factor: 4.123

9.  Tensile Viscoelastic Properties of the Sclera after Glycosaminoglycan Depletion.

Authors:  Hamed Hatami-Marbini; Mohammad Pachenari
Journal:  Curr Eye Res       Date:  2021-07-30       Impact factor: 2.555

Review 10.  Mimicking Extracellular Matrix via Engineered Nanostructured Biomaterials for Neural Repair.

Authors:  Andrea Raspa; Fabrizio Gelain
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.